You are currently viewing the editor's summary.
View Full TextLog in to view the full text
AAAS login provides access to Science for AAAS members, and access to other journals in the Science family to users who have purchased individual subscriptions.
Register for free to read this article
As a service to the community, this article is available for free. Existing users log in.
More options
Download and print this article for your personal scholarly, research, and educational use.
Buy a single issue of Science for just $15 USD.
Selective Inhibition
Interferon-γ (IFN-γ) activates the Janus kinase–signal transducer and activator of transcription (JAK-STAT) pathway to stimulate the production of the proinflammatory mediators that are required for an appropriate immune response. Defects in a required negative regulatory mechanism mediated by suppressor of cytokine signaling (SOCS) proteins are implicated in chronic inflammatory conditions. DiGiandomenico et al. engineered a cell-penetrating form of SOCS1 (CP-SOCS1) expressed in a human cell line that specifically targeted STAT1 to block IFN-γ–induced production of proinflammatory cytokines and chemokines by macrophages. The application of cell-penetrating proteins produced in human cells has advantages both for research and for potential clinical applications over recombinant proteins purified from bacteria. In addition, CP-SOCS1 may provide a therapeutic strategy against inflammatory diseases.
